What is Arjo AB?
Arjo AB (publ) develops and sells medical devices and solutions for patients for clinical and financial outcomes for healthcare in Europe, Asia, Latin America, Africa, and the Pacific.
0HQ8 · Verdict
Moderate reward · low risk
0HQ8 stands out on cash flow and balance sheet, but watch the profitability signal.
Based on 75% data coverage
0HQ8 · Verdict
Top decile vs peers
Current ratio 1.54
Above average
4% return on equity
Model-based scoring. For information only — not financial advice.
Arjo AB (publ) develops and sells medical devices and solutions for patients for clinical and financial outcomes for healthcare in Europe, Asia, Latin America, Africa, and the Pacific. It offers products and solutions for patient handling, hygiene, disinfection, medical beds, pressure injury prevention, diagnostics, hygiene, prevention of pressure injuries and blood clots, and leg ulcer treatment and prevention, as well as for obstetric and cardiac diagnostics. The company is listed on the LSE in UK, with a market capitalisation of 21.70B.
The scoring profile indicates limited reward potential at this time, with valuation and growth offering the most support. Risk indicators are low, suggesting a relatively contained downside profile.
For informational purposes only. Not financial advice.